| Purpose | Announcement Date | Ex-Date | Record Date | Dividend Amount | Dividend per Share | Remark |
|---|---|---|---|---|---|---|
| Dividend | 20 May 2026 | 22 Sep 2026 | 22 Sep 2026 | 0.5 | 5 | Final |
| The Board has recommended final dividend of Rs. 0.50 (Fifty paise only) per Equity Share of face value of Rs. 10/- (Rupees Ten only) each fully paid up for the Financial Year 2025-26. Remus Pharmaceuticals Limited has informed the Exchange that Record date for the purpose of Dividend is 22-Sep-2026. As Per Nse Announcement Dated On 07.09.2026 | ||||||
| Dividend | 10 Nov 2025 | 14 Nov 2025 | 14 Nov 2025 | 0.5 | 5 | Interim 1 |
| The Board has approved 01st Interim Dividend of Rs. 0.50 (Fifty paise only) per equity share of face value of Rs. 10/- (Rupees Ten only) each fully paid up for the Financial Year 2025-26. The record date for the purpose of payment of Interim Dividend, as intimated earlier will be November 14, 2025. | ||||||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.